Stakeholder Engagement in Type 1 Diabetes Research, Quality Improvement, and Clinical Care

Endocrinol Metab Clin North Am. 2024 Mar;53(1):165-182. doi: 10.1016/j.ecl.2023.09.007. Epub 2023 Dec 7.

Abstract

The integration of stakeholder engagement (SE) in research, quality improvement (QI), and clinical care has gained significant traction. Type 1 diabetes is a chronic disease that requires complex daily management and care from a multidisciplinary team across the lifespan. Inclusion of key stakeholder voices, including patients, caregivers, health care providers and community advocates, in the research process and implementation of clinical care is critical to ensure representation of perspectives that match the values and goals of the patient population. This review describes the current framework for SE and its application to research, QI, and clinical care across the lifespan.

Keywords: Partnership approaches; Public and patient involvement; Quality improvement; Stakeholder engagement; Type 1 diabetes.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus, Type 1* / therapy
  • Health Personnel
  • Humans
  • Quality Improvement
  • Stakeholder Participation